nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenytoin—CYP2B6—Thiotepa—urinary bladder cancer	0.0787	0.131	CbGbCtD
Phenytoin—SLCO1C1—Methotrexate—urinary bladder cancer	0.0776	0.129	CbGbCtD
Phenytoin—ABCB1—Mitomycin—urinary bladder cancer	0.0532	0.0884	CbGbCtD
Phenytoin—ABCC2—Carboplatin—urinary bladder cancer	0.04	0.0664	CbGbCtD
Phenytoin—ABCC2—Cisplatin—urinary bladder cancer	0.0341	0.0567	CbGbCtD
Phenytoin—ABCC2—Etoposide—urinary bladder cancer	0.0335	0.0557	CbGbCtD
Phenytoin—ALB—Fluorouracil—urinary bladder cancer	0.025	0.0416	CbGbCtD
Phenytoin—CYP3A4—Thiotepa—urinary bladder cancer	0.0242	0.0402	CbGbCtD
Phenytoin—ABCC2—Doxorubicin—urinary bladder cancer	0.0229	0.038	CbGbCtD
Phenytoin—ABCC2—Methotrexate—urinary bladder cancer	0.0222	0.0368	CbGbCtD
Phenytoin—CYP2B6—Cisplatin—urinary bladder cancer	0.0217	0.0361	CbGbCtD
Phenytoin—CYP2C8—Fluorouracil—urinary bladder cancer	0.0194	0.0322	CbGbCtD
Phenytoin—CYP3A5—Etoposide—urinary bladder cancer	0.0168	0.0279	CbGbCtD
Phenytoin—CYP2C8—Etoposide—urinary bladder cancer	0.0162	0.0268	CbGbCtD
Phenytoin—ABCB1—Gemcitabine—urinary bladder cancer	0.0153	0.0255	CbGbCtD
Phenytoin—CYP2B6—Doxorubicin—urinary bladder cancer	0.0145	0.0242	CbGbCtD
Phenytoin—ALB—Methotrexate—urinary bladder cancer	0.0138	0.023	CbGbCtD
Phenytoin—CYP2C9—Fluorouracil—urinary bladder cancer	0.0135	0.0224	CbGbCtD
Phenytoin—CYP2C9—Cisplatin—urinary bladder cancer	0.0115	0.0191	CbGbCtD
Phenytoin—ABCB1—Cisplatin—urinary bladder cancer	0.0111	0.0185	CbGbCtD
Phenytoin—ABCB1—Etoposide—urinary bladder cancer	0.0109	0.0182	CbGbCtD
Phenytoin—ABCB1—Doxorubicin—urinary bladder cancer	0.00746	0.0124	CbGbCtD
Phenytoin—ABCB1—Methotrexate—urinary bladder cancer	0.00723	0.012	CbGbCtD
Phenytoin—CYP3A4—Etoposide—urinary bladder cancer	0.00655	0.0109	CbGbCtD
Phenytoin—CYP3A4—Doxorubicin—urinary bladder cancer	0.00447	0.00743	CbGbCtD
Phenytoin—CYP2C19—urine—urinary bladder cancer	0.00273	0.081	CbGeAlD
Phenytoin—Phenobarbital—CYP4B1—urinary bladder cancer	0.00253	0.46	CrCbGaD
Phenytoin—SCN9A—prostate gland—urinary bladder cancer	0.0022	0.0652	CbGeAlD
Phenytoin—CYP2C9—urine—urinary bladder cancer	0.00212	0.0628	CbGeAlD
Phenytoin—SCN4A—prostate gland—urinary bladder cancer	0.00196	0.0582	CbGeAlD
Phenytoin—CYP3A4—urine—urinary bladder cancer	0.00162	0.0479	CbGeAlD
Phenytoin—SCN3A—prostate gland—urinary bladder cancer	0.00153	0.0452	CbGeAlD
Phenytoin—SLCO1C1—renal system—urinary bladder cancer	0.00146	0.0431	CbGeAlD
Phenytoin—SCN4A—renal system—urinary bladder cancer	0.00134	0.0396	CbGeAlD
Phenytoin—Benzphetamine—POR—urinary bladder cancer	0.00126	0.229	CrCbGaD
Phenytoin—ABCC2—prostate gland—urinary bladder cancer	0.00114	0.0338	CbGeAlD
Phenytoin—CYP2C18—vagina—urinary bladder cancer	0.00114	0.0338	CbGeAlD
Phenytoin—Carbamazepine—UGT2B7—urinary bladder cancer	0.00108	0.197	CrCbGaD
Phenytoin—SCN3A—renal system—urinary bladder cancer	0.00104	0.0308	CbGeAlD
Phenytoin—SCN2A—vagina—urinary bladder cancer	0.000858	0.0254	CbGeAlD
Phenytoin—SCN3A—female reproductive system—urinary bladder cancer	0.000834	0.0247	CbGeAlD
Phenytoin—ABCC2—renal system—urinary bladder cancer	0.000778	0.0231	CbGeAlD
Phenytoin—CYP3A5—prostate gland—urinary bladder cancer	0.000773	0.0229	CbGeAlD
Phenytoin—SCN3A—vagina—urinary bladder cancer	0.000754	0.0223	CbGeAlD
Phenytoin—SCN5A—vagina—urinary bladder cancer	0.000752	0.0223	CbGeAlD
Phenytoin—SCN9A—lymph node—urinary bladder cancer	0.000703	0.0208	CbGeAlD
Phenytoin—SLCO1C1—lymph node—urinary bladder cancer	0.000682	0.0202	CbGeAlD
Phenytoin—ABCC2—female reproductive system—urinary bladder cancer	0.000623	0.0185	CbGeAlD
Phenytoin—CYP2C8—renal system—urinary bladder cancer	0.000584	0.0173	CbGeAlD
Phenytoin—CYP3A5—renal system—urinary bladder cancer	0.000527	0.0156	CbGeAlD
Phenytoin—CYP2B6—renal system—urinary bladder cancer	0.000524	0.0155	CbGeAlD
Phenytoin—SCN3A—lymph node—urinary bladder cancer	0.000488	0.0144	CbGeAlD
Phenytoin—CYP2C19—vagina—urinary bladder cancer	0.000485	0.0144	CbGeAlD
Phenytoin—CYP2C8—female reproductive system—urinary bladder cancer	0.000468	0.0138	CbGeAlD
Phenytoin—CYP2C8—vagina—urinary bladder cancer	0.000423	0.0125	CbGeAlD
Phenytoin—CYP2B6—female reproductive system—urinary bladder cancer	0.000419	0.0124	CbGeAlD
Phenytoin—CYP2C9—female reproductive system—urinary bladder cancer	0.000415	0.0123	CbGeAlD
Phenytoin—ABCB1—prostate gland—urinary bladder cancer	0.000411	0.0122	CbGeAlD
Phenytoin—CYP3A4—renal system—urinary bladder cancer	0.000395	0.0117	CbGeAlD
Phenytoin—ALB—lymph node—urinary bladder cancer	0.000389	0.0115	CbGeAlD
Phenytoin—CYP3A5—vagina—urinary bladder cancer	0.000382	0.0113	CbGeAlD
Phenytoin—CYP2B6—vagina—urinary bladder cancer	0.000379	0.0112	CbGeAlD
Phenytoin—Oxaprozin—PTGS2—urinary bladder cancer	0.000377	0.0686	CrCbGaD
Phenytoin—ABCC2—lymph node—urinary bladder cancer	0.000365	0.0108	CbGeAlD
Phenytoin—ABCB1—seminal vesicle—urinary bladder cancer	0.000347	0.0103	CbGeAlD
Phenytoin—CYP3A4—female reproductive system—urinary bladder cancer	0.000317	0.00938	CbGeAlD
Phenytoin—ABCB1—epithelium—urinary bladder cancer	0.000302	0.00894	CbGeAlD
Phenytoin—ABCB1—renal system—urinary bladder cancer	0.00028	0.00829	CbGeAlD
Phenytoin—ABCB1—urethra—urinary bladder cancer	0.000275	0.00814	CbGeAlD
Phenytoin—Phenylbutazone—PTGS2—urinary bladder cancer	0.000249	0.0454	CrCbGaD
Phenytoin—ABCB1—female reproductive system—urinary bladder cancer	0.000224	0.00664	CbGeAlD
Phenytoin—ABCB1—vagina—urinary bladder cancer	0.000203	0.00601	CbGeAlD
Phenytoin—ABCB1—lymph node—urinary bladder cancer	0.000131	0.00388	CbGeAlD
Phenytoin—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000115	0.000456	CcSEcCtD
Phenytoin—Decreased appetite—Etoposide—urinary bladder cancer	0.000114	0.000455	CcSEcCtD
Phenytoin—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000114	0.000453	CcSEcCtD
Phenytoin—Renal failure—Epirubicin—urinary bladder cancer	0.000114	0.000452	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000114	0.000452	CcSEcCtD
Phenytoin—Body temperature increased—Cisplatin—urinary bladder cancer	0.000114	0.000451	CcSEcCtD
Phenytoin—Fatigue—Etoposide—urinary bladder cancer	0.000113	0.000451	CcSEcCtD
Phenytoin—Constipation—Etoposide—urinary bladder cancer	0.000113	0.000447	CcSEcCtD
Phenytoin—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000112	0.000447	CcSEcCtD
Phenytoin—Dysuria—Doxorubicin—urinary bladder cancer	0.000112	0.000446	CcSEcCtD
Phenytoin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000112	0.000444	CcSEcCtD
Phenytoin—Haemoglobin—Methotrexate—urinary bladder cancer	0.000111	0.000443	CcSEcCtD
Phenytoin—Haemorrhage—Methotrexate—urinary bladder cancer	0.000111	0.000441	CcSEcCtD
Phenytoin—Sweating—Epirubicin—urinary bladder cancer	0.000111	0.000441	CcSEcCtD
Phenytoin—Asthenia—Gemcitabine—urinary bladder cancer	0.000111	0.00044	CcSEcCtD
Phenytoin—Pharyngitis—Methotrexate—urinary bladder cancer	0.00011	0.000438	CcSEcCtD
Phenytoin—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.00011	0.000436	CcSEcCtD
Phenytoin—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000109	0.000435	CcSEcCtD
Phenytoin—Epistaxis—Epirubicin—urinary bladder cancer	0.000109	0.000434	CcSEcCtD
Phenytoin—Pruritus—Gemcitabine—urinary bladder cancer	0.000109	0.000433	CcSEcCtD
Phenytoin—Nausea—Thiotepa—urinary bladder cancer	0.000109	0.000433	CcSEcCtD
Phenytoin—Weight decreased—Doxorubicin—urinary bladder cancer	0.000109	0.000432	CcSEcCtD
Phenytoin—Sinusitis—Epirubicin—urinary bladder cancer	0.000108	0.000431	CcSEcCtD
Phenytoin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000108	0.000431	CcSEcCtD
Phenytoin—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000108	0.00043	CcSEcCtD
Phenytoin—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000108	0.000429	CcSEcCtD
Phenytoin—Pneumonia—Doxorubicin—urinary bladder cancer	0.000108	0.000428	CcSEcCtD
Phenytoin—Pruritus—Fluorouracil—urinary bladder cancer	0.000107	0.000426	CcSEcCtD
Phenytoin—Drowsiness—Doxorubicin—urinary bladder cancer	0.000107	0.000425	CcSEcCtD
Phenytoin—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000106	0.000422	CcSEcCtD
Phenytoin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000106	0.000421	CcSEcCtD
Phenytoin—Bradycardia—Epirubicin—urinary bladder cancer	0.000106	0.00042	CcSEcCtD
Phenytoin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000105	0.000419	CcSEcCtD
Phenytoin—Renal failure—Doxorubicin—urinary bladder cancer	0.000105	0.000418	CcSEcCtD
Phenytoin—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000105	0.000417	CcSEcCtD
Phenytoin—Urticaria—Etoposide—urinary bladder cancer	0.000105	0.000416	CcSEcCtD
Phenytoin—Haemoglobin—Epirubicin—urinary bladder cancer	0.000104	0.000415	CcSEcCtD
Phenytoin—Rhinitis—Epirubicin—urinary bladder cancer	0.000104	0.000414	CcSEcCtD
Phenytoin—Body temperature increased—Etoposide—urinary bladder cancer	0.000104	0.000414	CcSEcCtD
Phenytoin—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000104	0.000414	CcSEcCtD
Phenytoin—Haemorrhage—Epirubicin—urinary bladder cancer	0.000104	0.000413	CcSEcCtD
Phenytoin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000104	0.000412	CcSEcCtD
Phenytoin—Tinnitus—Methotrexate—urinary bladder cancer	0.000103	0.000411	CcSEcCtD
Phenytoin—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000103	0.000411	CcSEcCtD
Phenytoin—Asthenia—Cisplatin—urinary bladder cancer	0.000103	0.00041	CcSEcCtD
Phenytoin—Pharyngitis—Epirubicin—urinary bladder cancer	0.000103	0.00041	CcSEcCtD
Phenytoin—Sweating—Doxorubicin—urinary bladder cancer	0.000103	0.000408	CcSEcCtD
Phenytoin—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000102	0.000406	CcSEcCtD
Phenytoin—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000101	0.000402	CcSEcCtD
Phenytoin—Epistaxis—Doxorubicin—urinary bladder cancer	0.000101	0.000401	CcSEcCtD
Phenytoin—Sinusitis—Doxorubicin—urinary bladder cancer	0.0001	0.000399	CcSEcCtD
Phenytoin—Immune system disorder—Methotrexate—urinary bladder cancer	0.0001	0.000398	CcSEcCtD
Phenytoin—Dizziness—Fluorouracil—urinary bladder cancer	0.0001	0.000398	CcSEcCtD
Phenytoin—Agranulocytosis—Doxorubicin—urinary bladder cancer	9.99e-05	0.000397	CcSEcCtD
Phenytoin—Chills—Methotrexate—urinary bladder cancer	9.95e-05	0.000396	CcSEcCtD
Phenytoin—Diarrhoea—Cisplatin—urinary bladder cancer	9.83e-05	0.000391	CcSEcCtD
Phenytoin—Erythema multiforme—Epirubicin—urinary bladder cancer	9.82e-05	0.00039	CcSEcCtD
Phenytoin—Vomiting—Gemcitabine—urinary bladder cancer	9.8e-05	0.00039	CcSEcCtD
Phenytoin—Bradycardia—Doxorubicin—urinary bladder cancer	9.78e-05	0.000389	CcSEcCtD
Phenytoin—Rash—Gemcitabine—urinary bladder cancer	9.72e-05	0.000386	CcSEcCtD
Phenytoin—Dermatitis—Gemcitabine—urinary bladder cancer	9.71e-05	0.000386	CcSEcCtD
Phenytoin—Hypersensitivity—Etoposide—urinary bladder cancer	9.69e-05	0.000385	CcSEcCtD
Phenytoin—Tinnitus—Epirubicin—urinary bladder cancer	9.68e-05	0.000385	CcSEcCtD
Phenytoin—Haemoglobin—Doxorubicin—urinary bladder cancer	9.65e-05	0.000384	CcSEcCtD
Phenytoin—Headache—Gemcitabine—urinary bladder cancer	9.65e-05	0.000384	CcSEcCtD
Phenytoin—Vomiting—Fluorouracil—urinary bladder cancer	9.63e-05	0.000383	CcSEcCtD
Phenytoin—Rhinitis—Doxorubicin—urinary bladder cancer	9.63e-05	0.000383	CcSEcCtD
Phenytoin—Haemorrhage—Doxorubicin—urinary bladder cancer	9.61e-05	0.000382	CcSEcCtD
Phenytoin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	9.56e-05	0.00038	CcSEcCtD
Phenytoin—Rash—Fluorouracil—urinary bladder cancer	9.55e-05	0.00038	CcSEcCtD
Phenytoin—Dermatitis—Fluorouracil—urinary bladder cancer	9.54e-05	0.000379	CcSEcCtD
Phenytoin—Pharyngitis—Doxorubicin—urinary bladder cancer	9.53e-05	0.000379	CcSEcCtD
Phenytoin—Headache—Fluorouracil—urinary bladder cancer	9.49e-05	0.000377	CcSEcCtD
Phenytoin—Dysgeusia—Methotrexate—urinary bladder cancer	9.46e-05	0.000376	CcSEcCtD
Phenytoin—Asthenia—Etoposide—urinary bladder cancer	9.44e-05	0.000375	CcSEcCtD
Phenytoin—Connective tissue disorder—Doxorubicin—urinary bladder cancer	9.44e-05	0.000375	CcSEcCtD
Phenytoin—Immune system disorder—Epirubicin—urinary bladder cancer	9.38e-05	0.000373	CcSEcCtD
Phenytoin—Back pain—Methotrexate—urinary bladder cancer	9.34e-05	0.000371	CcSEcCtD
Phenytoin—Chills—Epirubicin—urinary bladder cancer	9.32e-05	0.00037	CcSEcCtD
Phenytoin—Pruritus—Etoposide—urinary bladder cancer	9.31e-05	0.00037	CcSEcCtD
Phenytoin—Nausea—Gemcitabine—urinary bladder cancer	9.15e-05	0.000364	CcSEcCtD
Phenytoin—Vomiting—Cisplatin—urinary bladder cancer	9.13e-05	0.000363	CcSEcCtD
Phenytoin—Erythema multiforme—Doxorubicin—urinary bladder cancer	9.08e-05	0.000361	CcSEcCtD
Phenytoin—Rash—Cisplatin—urinary bladder cancer	9.06e-05	0.00036	CcSEcCtD
Phenytoin—Dermatitis—Cisplatin—urinary bladder cancer	9.05e-05	0.00036	CcSEcCtD
Phenytoin—Diarrhoea—Etoposide—urinary bladder cancer	9e-05	0.000358	CcSEcCtD
Phenytoin—Nausea—Fluorouracil—urinary bladder cancer	9e-05	0.000358	CcSEcCtD
Phenytoin—Ill-defined disorder—Methotrexate—urinary bladder cancer	8.96e-05	0.000356	CcSEcCtD
Phenytoin—Tinnitus—Doxorubicin—urinary bladder cancer	8.96e-05	0.000356	CcSEcCtD
Phenytoin—Anaemia—Methotrexate—urinary bladder cancer	8.93e-05	0.000355	CcSEcCtD
Phenytoin—Flatulence—Epirubicin—urinary bladder cancer	8.91e-05	0.000354	CcSEcCtD
Phenytoin—Tension—Epirubicin—urinary bladder cancer	8.87e-05	0.000353	CcSEcCtD
Phenytoin—Dysgeusia—Epirubicin—urinary bladder cancer	8.85e-05	0.000352	CcSEcCtD
Phenytoin—Nervousness—Epirubicin—urinary bladder cancer	8.78e-05	0.000349	CcSEcCtD
Phenytoin—Back pain—Epirubicin—urinary bladder cancer	8.74e-05	0.000348	CcSEcCtD
Phenytoin—Malaise—Methotrexate—urinary bladder cancer	8.71e-05	0.000346	CcSEcCtD
Phenytoin—Dizziness—Etoposide—urinary bladder cancer	8.7e-05	0.000346	CcSEcCtD
Phenytoin—Muscle spasms—Epirubicin—urinary bladder cancer	8.69e-05	0.000345	CcSEcCtD
Phenytoin—Immune system disorder—Doxorubicin—urinary bladder cancer	8.68e-05	0.000345	CcSEcCtD
Phenytoin—Vertigo—Methotrexate—urinary bladder cancer	8.68e-05	0.000345	CcSEcCtD
Phenytoin—Leukopenia—Methotrexate—urinary bladder cancer	8.64e-05	0.000344	CcSEcCtD
Phenytoin—Chills—Doxorubicin—urinary bladder cancer	8.62e-05	0.000343	CcSEcCtD
Phenytoin—Nausea—Cisplatin—urinary bladder cancer	8.53e-05	0.000339	CcSEcCtD
Phenytoin—Cough—Methotrexate—urinary bladder cancer	8.43e-05	0.000335	CcSEcCtD
Phenytoin—Ill-defined disorder—Epirubicin—urinary bladder cancer	8.39e-05	0.000333	CcSEcCtD
Phenytoin—Convulsion—Methotrexate—urinary bladder cancer	8.37e-05	0.000333	CcSEcCtD
Phenytoin—Vomiting—Etoposide—urinary bladder cancer	8.37e-05	0.000333	CcSEcCtD
Phenytoin—Anaemia—Epirubicin—urinary bladder cancer	8.35e-05	0.000332	CcSEcCtD
Phenytoin—Agitation—Epirubicin—urinary bladder cancer	8.31e-05	0.00033	CcSEcCtD
Phenytoin—Rash—Etoposide—urinary bladder cancer	8.3e-05	0.00033	CcSEcCtD
Phenytoin—Dermatitis—Etoposide—urinary bladder cancer	8.29e-05	0.00033	CcSEcCtD
Phenytoin—Headache—Etoposide—urinary bladder cancer	8.24e-05	0.000328	CcSEcCtD
Phenytoin—Flatulence—Doxorubicin—urinary bladder cancer	8.24e-05	0.000328	CcSEcCtD
Phenytoin—Chest pain—Methotrexate—urinary bladder cancer	8.22e-05	0.000327	CcSEcCtD
Phenytoin—Myalgia—Methotrexate—urinary bladder cancer	8.22e-05	0.000327	CcSEcCtD
Phenytoin—Arthralgia—Methotrexate—urinary bladder cancer	8.22e-05	0.000327	CcSEcCtD
Phenytoin—Tension—Doxorubicin—urinary bladder cancer	8.21e-05	0.000326	CcSEcCtD
Phenytoin—Dysgeusia—Doxorubicin—urinary bladder cancer	8.19e-05	0.000326	CcSEcCtD
Phenytoin—Malaise—Epirubicin—urinary bladder cancer	8.15e-05	0.000324	CcSEcCtD
Phenytoin—Discomfort—Methotrexate—urinary bladder cancer	8.12e-05	0.000323	CcSEcCtD
Phenytoin—Nervousness—Doxorubicin—urinary bladder cancer	8.12e-05	0.000323	CcSEcCtD
Phenytoin—Vertigo—Epirubicin—urinary bladder cancer	8.12e-05	0.000323	CcSEcCtD
Phenytoin—Syncope—Epirubicin—urinary bladder cancer	8.1e-05	0.000322	CcSEcCtD
Phenytoin—Leukopenia—Epirubicin—urinary bladder cancer	8.09e-05	0.000322	CcSEcCtD
Phenytoin—Back pain—Doxorubicin—urinary bladder cancer	8.09e-05	0.000322	CcSEcCtD
Phenytoin—Muscle spasms—Doxorubicin—urinary bladder cancer	8.04e-05	0.00032	CcSEcCtD
Phenytoin—Palpitations—Epirubicin—urinary bladder cancer	7.99e-05	0.000318	CcSEcCtD
Phenytoin—Confusional state—Methotrexate—urinary bladder cancer	7.95e-05	0.000316	CcSEcCtD
Phenytoin—Loss of consciousness—Epirubicin—urinary bladder cancer	7.94e-05	0.000316	CcSEcCtD
Phenytoin—Cough—Epirubicin—urinary bladder cancer	7.89e-05	0.000314	CcSEcCtD
Phenytoin—Anaphylactic shock—Methotrexate—urinary bladder cancer	7.88e-05	0.000313	CcSEcCtD
Phenytoin—Convulsion—Epirubicin—urinary bladder cancer	7.83e-05	0.000311	CcSEcCtD
Phenytoin—Infection—Methotrexate—urinary bladder cancer	7.83e-05	0.000311	CcSEcCtD
Phenytoin—Nausea—Etoposide—urinary bladder cancer	7.82e-05	0.000311	CcSEcCtD
Phenytoin—Hypertension—Epirubicin—urinary bladder cancer	7.8e-05	0.00031	CcSEcCtD
Phenytoin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	7.76e-05	0.000308	CcSEcCtD
Phenytoin—Nervous system disorder—Methotrexate—urinary bladder cancer	7.73e-05	0.000307	CcSEcCtD
Phenytoin—Anaemia—Doxorubicin—urinary bladder cancer	7.73e-05	0.000307	CcSEcCtD
Phenytoin—Thrombocytopenia—Methotrexate—urinary bladder cancer	7.72e-05	0.000307	CcSEcCtD
Phenytoin—Myalgia—Epirubicin—urinary bladder cancer	7.69e-05	0.000306	CcSEcCtD
Phenytoin—Chest pain—Epirubicin—urinary bladder cancer	7.69e-05	0.000306	CcSEcCtD
Phenytoin—Arthralgia—Epirubicin—urinary bladder cancer	7.69e-05	0.000306	CcSEcCtD
Phenytoin—Agitation—Doxorubicin—urinary bladder cancer	7.68e-05	0.000306	CcSEcCtD
Phenytoin—Hyperhidrosis—Methotrexate—urinary bladder cancer	7.62e-05	0.000303	CcSEcCtD
Phenytoin—Discomfort—Epirubicin—urinary bladder cancer	7.6e-05	0.000302	CcSEcCtD
Phenytoin—Malaise—Doxorubicin—urinary bladder cancer	7.54e-05	0.0003	CcSEcCtD
Phenytoin—Dry mouth—Epirubicin—urinary bladder cancer	7.52e-05	0.000299	CcSEcCtD
Phenytoin—Vertigo—Doxorubicin—urinary bladder cancer	7.51e-05	0.000299	CcSEcCtD
Phenytoin—Anorexia—Methotrexate—urinary bladder cancer	7.51e-05	0.000299	CcSEcCtD
Phenytoin—Syncope—Doxorubicin—urinary bladder cancer	7.5e-05	0.000298	CcSEcCtD
Phenytoin—Leukopenia—Doxorubicin—urinary bladder cancer	7.49e-05	0.000298	CcSEcCtD
Phenytoin—Confusional state—Epirubicin—urinary bladder cancer	7.44e-05	0.000296	CcSEcCtD
Phenytoin—Palpitations—Doxorubicin—urinary bladder cancer	7.39e-05	0.000294	CcSEcCtD
Phenytoin—Anaphylactic shock—Epirubicin—urinary bladder cancer	7.38e-05	0.000293	CcSEcCtD
Phenytoin—Hypotension—Methotrexate—urinary bladder cancer	7.36e-05	0.000293	CcSEcCtD
Phenytoin—Loss of consciousness—Doxorubicin—urinary bladder cancer	7.35e-05	0.000292	CcSEcCtD
Phenytoin—Infection—Epirubicin—urinary bladder cancer	7.33e-05	0.000291	CcSEcCtD
Phenytoin—Cough—Doxorubicin—urinary bladder cancer	7.3e-05	0.00029	CcSEcCtD
Phenytoin—Shock—Epirubicin—urinary bladder cancer	7.26e-05	0.000288	CcSEcCtD
Phenytoin—Convulsion—Doxorubicin—urinary bladder cancer	7.25e-05	0.000288	CcSEcCtD
Phenytoin—Nervous system disorder—Epirubicin—urinary bladder cancer	7.23e-05	0.000288	CcSEcCtD
Phenytoin—Thrombocytopenia—Epirubicin—urinary bladder cancer	7.22e-05	0.000287	CcSEcCtD
Phenytoin—Hypertension—Doxorubicin—urinary bladder cancer	7.22e-05	0.000287	CcSEcCtD
Phenytoin—Tachycardia—Epirubicin—urinary bladder cancer	7.2e-05	0.000286	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	7.18e-05	0.000285	CcSEcCtD
Phenytoin—Hyperhidrosis—Epirubicin—urinary bladder cancer	7.13e-05	0.000283	CcSEcCtD
Phenytoin—Insomnia—Methotrexate—urinary bladder cancer	7.13e-05	0.000283	CcSEcCtD
Phenytoin—Arthralgia—Doxorubicin—urinary bladder cancer	7.12e-05	0.000283	CcSEcCtD
Phenytoin—Myalgia—Doxorubicin—urinary bladder cancer	7.12e-05	0.000283	CcSEcCtD
Phenytoin—Chest pain—Doxorubicin—urinary bladder cancer	7.12e-05	0.000283	CcSEcCtD
Phenytoin—Paraesthesia—Methotrexate—urinary bladder cancer	7.08e-05	0.000281	CcSEcCtD
Phenytoin—Discomfort—Doxorubicin—urinary bladder cancer	7.03e-05	0.00028	CcSEcCtD
Phenytoin—Anorexia—Epirubicin—urinary bladder cancer	7.03e-05	0.00028	CcSEcCtD
Phenytoin—Dyspnoea—Methotrexate—urinary bladder cancer	7.03e-05	0.000279	CcSEcCtD
Phenytoin—Somnolence—Methotrexate—urinary bladder cancer	7.01e-05	0.000279	CcSEcCtD
Phenytoin—Dry mouth—Doxorubicin—urinary bladder cancer	6.96e-05	0.000277	CcSEcCtD
Phenytoin—Dyspepsia—Methotrexate—urinary bladder cancer	6.94e-05	0.000276	CcSEcCtD
Phenytoin—Hypotension—Epirubicin—urinary bladder cancer	6.89e-05	0.000274	CcSEcCtD
Phenytoin—Confusional state—Doxorubicin—urinary bladder cancer	6.88e-05	0.000274	CcSEcCtD
Phenytoin—Decreased appetite—Methotrexate—urinary bladder cancer	6.85e-05	0.000272	CcSEcCtD
Phenytoin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	6.82e-05	0.000271	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	6.8e-05	0.000271	CcSEcCtD
Phenytoin—Fatigue—Methotrexate—urinary bladder cancer	6.8e-05	0.00027	CcSEcCtD
Phenytoin—Infection—Doxorubicin—urinary bladder cancer	6.78e-05	0.00027	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	6.72e-05	0.000267	CcSEcCtD
Phenytoin—Shock—Doxorubicin—urinary bladder cancer	6.71e-05	0.000267	CcSEcCtD
Phenytoin—Nervous system disorder—Doxorubicin—urinary bladder cancer	6.69e-05	0.000266	CcSEcCtD
Phenytoin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	6.68e-05	0.000266	CcSEcCtD
Phenytoin—Insomnia—Epirubicin—urinary bladder cancer	6.67e-05	0.000265	CcSEcCtD
Phenytoin—Tachycardia—Doxorubicin—urinary bladder cancer	6.66e-05	0.000265	CcSEcCtD
Phenytoin—Paraesthesia—Epirubicin—urinary bladder cancer	6.62e-05	0.000263	CcSEcCtD
Phenytoin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	6.6e-05	0.000262	CcSEcCtD
Phenytoin—Dyspnoea—Epirubicin—urinary bladder cancer	6.58e-05	0.000261	CcSEcCtD
Phenytoin—Somnolence—Epirubicin—urinary bladder cancer	6.56e-05	0.000261	CcSEcCtD
Phenytoin—Anorexia—Doxorubicin—urinary bladder cancer	6.51e-05	0.000259	CcSEcCtD
Phenytoin—Feeling abnormal—Methotrexate—urinary bladder cancer	6.49e-05	0.000258	CcSEcCtD
Phenytoin—Dyspepsia—Epirubicin—urinary bladder cancer	6.49e-05	0.000258	CcSEcCtD
Phenytoin—Decreased appetite—Epirubicin—urinary bladder cancer	6.41e-05	0.000255	CcSEcCtD
Phenytoin—Hypotension—Doxorubicin—urinary bladder cancer	6.38e-05	0.000254	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	6.37e-05	0.000253	CcSEcCtD
Phenytoin—Fatigue—Epirubicin—urinary bladder cancer	6.36e-05	0.000253	CcSEcCtD
Phenytoin—Constipation—Epirubicin—urinary bladder cancer	6.31e-05	0.000251	CcSEcCtD
Phenytoin—Urticaria—Methotrexate—urinary bladder cancer	6.26e-05	0.000249	CcSEcCtD
Phenytoin—Body temperature increased—Methotrexate—urinary bladder cancer	6.23e-05	0.000248	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	6.22e-05	0.000247	CcSEcCtD
Phenytoin—Insomnia—Doxorubicin—urinary bladder cancer	6.17e-05	0.000245	CcSEcCtD
Phenytoin—Paraesthesia—Doxorubicin—urinary bladder cancer	6.13e-05	0.000244	CcSEcCtD
Phenytoin—Dyspnoea—Doxorubicin—urinary bladder cancer	6.08e-05	0.000242	CcSEcCtD
Phenytoin—Feeling abnormal—Epirubicin—urinary bladder cancer	6.08e-05	0.000242	CcSEcCtD
Phenytoin—Somnolence—Doxorubicin—urinary bladder cancer	6.07e-05	0.000241	CcSEcCtD
Phenytoin—Dyspepsia—Doxorubicin—urinary bladder cancer	6.01e-05	0.000239	CcSEcCtD
Phenytoin—Decreased appetite—Doxorubicin—urinary bladder cancer	5.93e-05	0.000236	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	5.89e-05	0.000234	CcSEcCtD
Phenytoin—Fatigue—Doxorubicin—urinary bladder cancer	5.88e-05	0.000234	CcSEcCtD
Phenytoin—Urticaria—Epirubicin—urinary bladder cancer	5.86e-05	0.000233	CcSEcCtD
Phenytoin—Constipation—Doxorubicin—urinary bladder cancer	5.84e-05	0.000232	CcSEcCtD
Phenytoin—Body temperature increased—Epirubicin—urinary bladder cancer	5.83e-05	0.000232	CcSEcCtD
Phenytoin—Hypersensitivity—Methotrexate—urinary bladder cancer	5.81e-05	0.000231	CcSEcCtD
Phenytoin—Asthenia—Methotrexate—urinary bladder cancer	5.65e-05	0.000225	CcSEcCtD
Phenytoin—Feeling abnormal—Doxorubicin—urinary bladder cancer	5.62e-05	0.000224	CcSEcCtD
Phenytoin—Pruritus—Methotrexate—urinary bladder cancer	5.58e-05	0.000222	CcSEcCtD
Phenytoin—Hypersensitivity—Epirubicin—urinary bladder cancer	5.43e-05	0.000216	CcSEcCtD
Phenytoin—Urticaria—Doxorubicin—urinary bladder cancer	5.42e-05	0.000216	CcSEcCtD
Phenytoin—Body temperature increased—Doxorubicin—urinary bladder cancer	5.39e-05	0.000214	CcSEcCtD
Phenytoin—Diarrhoea—Methotrexate—urinary bladder cancer	5.39e-05	0.000214	CcSEcCtD
Phenytoin—Asthenia—Epirubicin—urinary bladder cancer	5.29e-05	0.00021	CcSEcCtD
Phenytoin—Pruritus—Epirubicin—urinary bladder cancer	5.22e-05	0.000207	CcSEcCtD
Phenytoin—Dizziness—Methotrexate—urinary bladder cancer	5.21e-05	0.000207	CcSEcCtD
Phenytoin—Diarrhoea—Epirubicin—urinary bladder cancer	5.05e-05	0.000201	CcSEcCtD
Phenytoin—Hypersensitivity—Doxorubicin—urinary bladder cancer	5.03e-05	0.0002	CcSEcCtD
Phenytoin—Vomiting—Methotrexate—urinary bladder cancer	5.01e-05	0.000199	CcSEcCtD
Phenytoin—Rash—Methotrexate—urinary bladder cancer	4.97e-05	0.000198	CcSEcCtD
Phenytoin—Dermatitis—Methotrexate—urinary bladder cancer	4.96e-05	0.000197	CcSEcCtD
Phenytoin—Headache—Methotrexate—urinary bladder cancer	4.94e-05	0.000196	CcSEcCtD
Phenytoin—Asthenia—Doxorubicin—urinary bladder cancer	4.9e-05	0.000195	CcSEcCtD
Phenytoin—Dizziness—Epirubicin—urinary bladder cancer	4.88e-05	0.000194	CcSEcCtD
Phenytoin—Pruritus—Doxorubicin—urinary bladder cancer	4.83e-05	0.000192	CcSEcCtD
Phenytoin—Vomiting—Epirubicin—urinary bladder cancer	4.69e-05	0.000186	CcSEcCtD
Phenytoin—Nausea—Methotrexate—urinary bladder cancer	4.68e-05	0.000186	CcSEcCtD
Phenytoin—Diarrhoea—Doxorubicin—urinary bladder cancer	4.67e-05	0.000186	CcSEcCtD
Phenytoin—Rash—Epirubicin—urinary bladder cancer	4.65e-05	0.000185	CcSEcCtD
Phenytoin—Dermatitis—Epirubicin—urinary bladder cancer	4.65e-05	0.000185	CcSEcCtD
Phenytoin—Headache—Epirubicin—urinary bladder cancer	4.62e-05	0.000184	CcSEcCtD
Phenytoin—Dizziness—Doxorubicin—urinary bladder cancer	4.51e-05	0.000179	CcSEcCtD
Phenytoin—Nausea—Epirubicin—urinary bladder cancer	4.38e-05	0.000174	CcSEcCtD
Phenytoin—Vomiting—Doxorubicin—urinary bladder cancer	4.34e-05	0.000173	CcSEcCtD
Phenytoin—Rash—Doxorubicin—urinary bladder cancer	4.3e-05	0.000171	CcSEcCtD
Phenytoin—Dermatitis—Doxorubicin—urinary bladder cancer	4.3e-05	0.000171	CcSEcCtD
Phenytoin—Headache—Doxorubicin—urinary bladder cancer	4.28e-05	0.00017	CcSEcCtD
Phenytoin—Nausea—Doxorubicin—urinary bladder cancer	4.05e-05	0.000161	CcSEcCtD
Phenytoin—CYP3A5—Metabolism—TYMP—urinary bladder cancer	2.24e-05	0.000208	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	2.22e-05	0.000207	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—TNF—urinary bladder cancer	2.18e-05	0.000203	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	2.17e-05	0.000202	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	2.17e-05	0.000202	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—KRAS—urinary bladder cancer	2.17e-05	0.000202	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	2.16e-05	0.000201	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	2.15e-05	0.0002	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	2.14e-05	0.0002	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PRSS3—urinary bladder cancer	2.11e-05	0.000197	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—TYMS—urinary bladder cancer	2.1e-05	0.000196	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—NCOR1—urinary bladder cancer	2.08e-05	0.000194	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—GSTM1—urinary bladder cancer	2.08e-05	0.000194	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—NAT2—urinary bladder cancer	2.07e-05	0.000193	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.06e-05	0.000192	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	2.02e-05	0.000188	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—NAT2—urinary bladder cancer	2.02e-05	0.000188	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—PPARG—urinary bladder cancer	2.01e-05	0.000187	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2e-05	0.000186	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	1.99e-05	0.000186	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—GPX1—urinary bladder cancer	1.99e-05	0.000185	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	1.97e-05	0.000184	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—ERCC2—urinary bladder cancer	1.95e-05	0.000182	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.94e-05	0.000181	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—TYMP—urinary bladder cancer	1.94e-05	0.00018	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—CREBBP—urinary bladder cancer	1.93e-05	0.00018	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.93e-05	0.00018	CbGpPWpGaD
Phenytoin—ALB—Metabolism—TYMP—urinary bladder cancer	1.93e-05	0.000179	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	1.9e-05	0.000177	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	1.88e-05	0.000175	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.86e-05	0.000173	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.85e-05	0.000172	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	1.85e-05	0.000172	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—HRAS—urinary bladder cancer	1.84e-05	0.000171	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—MTHFR—urinary bladder cancer	1.84e-05	0.000171	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	1.81e-05	0.000169	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—NQO1—urinary bladder cancer	1.8e-05	0.000168	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—RRM2—urinary bladder cancer	1.79e-05	0.000166	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—PLAU—urinary bladder cancer	1.77e-05	0.000165	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—NAT2—urinary bladder cancer	1.75e-05	0.000163	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—RRM2—urinary bladder cancer	1.75e-05	0.000163	CbGpPWpGaD
Phenytoin—ALB—Metabolism—NAT2—urinary bladder cancer	1.74e-05	0.000162	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.73e-05	0.000161	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—TYMP—urinary bladder cancer	1.73e-05	0.000161	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	1.72e-05	0.00016	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—NAT1—urinary bladder cancer	1.72e-05	0.00016	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—TYMP—urinary bladder cancer	1.69e-05	0.000157	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.66e-05	0.000155	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	1.66e-05	0.000154	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—ENO2—urinary bladder cancer	1.65e-05	0.000154	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	1.65e-05	0.000154	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	1.62e-05	0.000151	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—ENO2—urinary bladder cancer	1.62e-05	0.000151	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	1.62e-05	0.000151	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	1.6e-05	0.000149	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—PTGS2—urinary bladder cancer	1.58e-05	0.000147	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.58e-05	0.000147	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—TYMP—urinary bladder cancer	1.58e-05	0.000147	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.57e-05	0.000146	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	1.57e-05	0.000146	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—NAT2—urinary bladder cancer	1.56e-05	0.000146	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.54e-05	0.000144	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.53e-05	0.000143	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—NAT2—urinary bladder cancer	1.53e-05	0.000142	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.51e-05	0.000141	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—RRM2—urinary bladder cancer	1.51e-05	0.000141	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	1.5e-05	0.00014	CbGpPWpGaD
Phenytoin—ALB—Metabolism—RRM2—urinary bladder cancer	1.5e-05	0.00014	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PPARG—urinary bladder cancer	1.49e-05	0.000139	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—CREBBP—urinary bladder cancer	1.46e-05	0.000136	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—IGF1—urinary bladder cancer	1.44e-05	0.000134	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—CREBBP—urinary bladder cancer	1.43e-05	0.000133	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—NAT2—urinary bladder cancer	1.43e-05	0.000133	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.41e-05	0.000132	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ENO2—urinary bladder cancer	1.4e-05	0.00013	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	1.4e-05	0.00013	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—TYMS—urinary bladder cancer	1.4e-05	0.00013	CbGpPWpGaD
Phenytoin—ALB—Metabolism—ENO2—urinary bladder cancer	1.39e-05	0.00013	CbGpPWpGaD
Phenytoin—ALB—Metabolism—HPGDS—urinary bladder cancer	1.39e-05	0.00013	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.39e-05	0.00013	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.38e-05	0.000129	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	1.38e-05	0.000129	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	1.38e-05	0.000129	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—PTEN—urinary bladder cancer	1.38e-05	0.000129	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.36e-05	0.000127	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	1.36e-05	0.000126	CbGpPWpGaD
Phenytoin—ALB—Metabolism—GSTT1—urinary bladder cancer	1.35e-05	0.000126	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—RRM2—urinary bladder cancer	1.35e-05	0.000126	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.34e-05	0.000125	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.33e-05	0.000124	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—NQO1—urinary bladder cancer	1.33e-05	0.000124	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.33e-05	0.000124	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—GPX1—urinary bladder cancer	1.32e-05	0.000123	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—RHOA—urinary bladder cancer	1.32e-05	0.000123	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.32e-05	0.000123	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—EP300—urinary bladder cancer	1.32e-05	0.000123	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—NQO1—urinary bladder cancer	1.3e-05	0.000121	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.3e-05	0.000121	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	1.3e-05	0.000121	CbGpPWpGaD
Phenytoin—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.26e-05	0.000118	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ENO2—urinary bladder cancer	1.25e-05	0.000116	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	1.25e-05	0.000116	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.24e-05	0.000116	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.23e-05	0.000115	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	1.22e-05	0.000114	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.22e-05	0.000114	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.22e-05	0.000114	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	1.21e-05	0.000113	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.19e-05	0.000111	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.18e-05	0.00011	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PTGS2—urinary bladder cancer	1.17e-05	0.000109	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.14e-05	0.000106	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.14e-05	0.000106	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.13e-05	0.000106	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—NQO1—urinary bladder cancer	1.13e-05	0.000105	CbGpPWpGaD
Phenytoin—ALB—Metabolism—NQO1—urinary bladder cancer	1.12e-05	0.000105	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	1.11e-05	0.000104	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—IL2—urinary bladder cancer	1.11e-05	0.000103	CbGpPWpGaD
Phenytoin—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.11e-05	0.000103	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.11e-05	0.000103	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.1e-05	0.000102	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.09e-05	0.000101	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.09e-05	0.000101	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	1.09e-05	0.000101	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.04e-05	9.68e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—TYMS—urinary bladder cancer	1.03e-05	9.63e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	1.02e-05	9.52e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	1.02e-05	9.52e-05	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PTEN—urinary bladder cancer	1.02e-05	9.52e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—TYMS—urinary bladder cancer	1.01e-05	9.41e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.01e-05	9.38e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	9.99e-06	9.3e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	9.99e-06	9.3e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—EP300—urinary bladder cancer	9.95e-06	9.26e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PPARG—urinary bladder cancer	9.9e-06	9.22e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—NQO1—urinary bladder cancer	9.84e-06	9.16e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—GPX1—urinary bladder cancer	9.79e-06	9.11e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	9.78e-06	9.1e-05	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—EP300—urinary bladder cancer	9.75e-06	9.08e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—SRC—urinary bladder cancer	9.68e-06	9.01e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	9.61e-06	8.95e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—GPX1—urinary bladder cancer	9.57e-06	8.91e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9.55e-06	8.89e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	9.52e-06	8.86e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9.5e-06	8.84e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	9.42e-06	8.77e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—NAT2—urinary bladder cancer	9.4e-06	8.76e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	9.39e-06	8.75e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—GSTP1—urinary bladder cancer	9.36e-06	8.72e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—NQO1—urinary bladder cancer	9.19e-06	8.56e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.11e-06	8.48e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.06e-06	8.43e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	9.03e-06	8.41e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.92e-06	8.3e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	8.83e-06	8.22e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—TYMS—urinary bladder cancer	8.75e-06	8.15e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—TYMS—urinary bladder cancer	8.7e-06	8.1e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	8.65e-06	8.06e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	8.65e-06	8.06e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—NCOR1—urinary bladder cancer	8.6e-06	8.01e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—GSTM1—urinary bladder cancer	8.6e-06	8.01e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.53e-06	7.94e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	8.41e-06	7.83e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—GPX1—urinary bladder cancer	8.29e-06	7.72e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—GPX1—urinary bladder cancer	8.24e-06	7.67e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—GSTP1—urinary bladder cancer	8.2e-06	7.64e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	8.14e-06	7.58e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.13e-06	7.57e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—RRM2—urinary bladder cancer	8.12e-06	7.56e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—ERCC2—urinary bladder cancer	8.09e-06	7.53e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—KRAS—urinary bladder cancer	8.01e-06	7.46e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—TYMS—urinary bladder cancer	7.81e-06	7.28e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	7.79e-06	7.25e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.77e-06	7.24e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	7.72e-06	7.19e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	7.72e-06	7.19e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	7.66e-06	7.14e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	7.65e-06	7.12e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—TYMS—urinary bladder cancer	7.63e-06	7.1e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—MTHFR—urinary bladder cancer	7.6e-06	7.08e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—GSTM1—urinary bladder cancer	7.54e-06	7.02e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—NCOR1—urinary bladder cancer	7.54e-06	7.02e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ENO2—urinary bladder cancer	7.52e-06	7e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	7.52e-06	7e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.41e-06	6.9e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—GPX1—urinary bladder cancer	7.4e-06	6.89e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PPARG—urinary bladder cancer	7.33e-06	6.82e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	7.29e-06	6.79e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	7.26e-06	6.76e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—GPX1—urinary bladder cancer	7.22e-06	6.72e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PPARG—urinary bladder cancer	7.16e-06	6.67e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—TYMS—urinary bladder cancer	7.12e-06	6.63e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—TP53—urinary bladder cancer	7.12e-06	6.63e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—ERCC2—urinary bladder cancer	7.09e-06	6.6e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	7.04e-06	6.56e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	7.04e-06	6.56e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	7.04e-06	6.55e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	6.88e-06	6.4e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	6.83e-06	6.36e-05	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—HRAS—urinary bladder cancer	6.81e-06	6.34e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PTEN—urinary bladder cancer	6.8e-06	6.33e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—GPX1—urinary bladder cancer	6.74e-06	6.28e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—MTHFR—urinary bladder cancer	6.66e-06	6.2e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	6.62e-06	6.17e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—EP300—urinary bladder cancer	6.48e-06	6.03e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	6.22e-06	5.8e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PPARG—urinary bladder cancer	6.2e-06	5.77e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PPARG—urinary bladder cancer	6.17e-06	5.74e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—NQO1—urinary bladder cancer	6.06e-06	5.64e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	5.96e-06	5.55e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CREBBP—urinary bladder cancer	5.92e-06	5.52e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	5.76e-06	5.37e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	5.63e-06	5.24e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PPARG—urinary bladder cancer	5.54e-06	5.15e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PPARG—urinary bladder cancer	5.4e-06	5.03e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	5.32e-06	4.95e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CREBBP—urinary bladder cancer	5.19e-06	4.83e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	5.05e-06	4.71e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PPARG—urinary bladder cancer	5.05e-06	4.7e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PTEN—urinary bladder cancer	5.03e-06	4.68e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PTEN—urinary bladder cancer	4.91e-06	4.57e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	4.88e-06	4.54e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PTGS2—urinary bladder cancer	4.85e-06	4.52e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	4.85e-06	4.51e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—EP300—urinary bladder cancer	4.79e-06	4.46e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—TYMS—urinary bladder cancer	4.7e-06	4.38e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—EP300—urinary bladder cancer	4.68e-06	4.36e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	4.64e-06	4.32e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	4.64e-06	4.32e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GPX1—urinary bladder cancer	4.45e-06	4.14e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	4.37e-06	4.07e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	4.35e-06	4.05e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PTEN—urinary bladder cancer	4.25e-06	3.96e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PTGS2—urinary bladder cancer	4.25e-06	3.96e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PTEN—urinary bladder cancer	4.23e-06	3.94e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	4.1e-06	3.82e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—EP300—urinary bladder cancer	4.06e-06	3.78e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—EP300—urinary bladder cancer	4.03e-06	3.76e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	3.97e-06	3.7e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PTEN—urinary bladder cancer	3.8e-06	3.54e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PTEN—urinary bladder cancer	3.71e-06	3.45e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—EP300—urinary bladder cancer	3.62e-06	3.37e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—EP300—urinary bladder cancer	3.53e-06	3.29e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PTEN—urinary bladder cancer	3.46e-06	3.22e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PPARG—urinary bladder cancer	3.33e-06	3.1e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—EP300—urinary bladder cancer	3.3e-06	3.07e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	3.2e-06	2.98e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.62e-06	2.44e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.28e-06	2.13e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.18e-06	2.03e-05	CbGpPWpGaD
